Acetazolamide C₄H₆N₄O₃S₂
Active ingredient description
Acetazolamide is an enzyme inhibitor which acts specifically on carbonic anhydrase. By inhibiting the reaction catalysed by this enzyme in the renal tubules, acetazolamide increases the excretion of bicarbonate and of cations, chiefly sodium and potassium, and so promotes alkaline diuresis. By inhibiting carbonic anhydrase in the eye acetazolamide decreases intra-ocular pressure and is therefore useful in the treatment of glaucoma.
Medicine classification
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Product monographs
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
Structural formula
Chemical formula: C₄H₆N₄O₃S₂
Molecular mass: 222.245 g/mol
3D molecular structure
External identifiers
Medicines
Acetazolamide is an active ingredient of these brands:
Australia (AU)
Austria (AT)
Brazil (BR)
Ecuador (EC)
France (FR)
Ireland (IE)
Japan (JP)
Lithuania (LT)
Netherlands (NL)
Poland (PL)
Spain (ES)
Tunisia (TN)
Turkey (TR)
United Kingdom (UK)
While we strive to include the brand names of medicines across all countries, our index remains incomplete. Therefore, it is possible that this medicine may also be marketed under different names in other countries.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.